企業レポート

世界の中枢神経系(CNS)治療薬市場:主要サプライヤーの評価

Global CNS Drug Market: Strategic Assessments of Leading Suppliers

発行 Venture Planning Group 商品コード 216709
出版日 ページ情報 英文
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=105.42円で換算しております。

Local License: 同一事業所内

Back to Top
世界の中枢神経系(CNS)治療薬市場:主要サプライヤーの評価 Global CNS Drug Market: Strategic Assessments of Leading Suppliers
出版日: ページ情報: 英文
概要

当レポートでは、世界の中枢神経系(CNS)治療薬市場における主要サプライヤーについて、実績、能力、目標、戦略、カテゴリー別/地域別の売上予測など包括的な情報を提供し、販売、提携や買収、マーケティング、R&Dにおいてサプライヤー、将来的に市場参入を考えている企業、競合他社などを支援するための情報をまとめており、概略以下の構成でお届けします。

目次

  • Abbott
    • エグゼクティブサマリー
    • 所有権
    • 事業展開
    • 組織とマネジメント
    • 主な施設
    • 製品のポートフォリオおよび技術的なノウハウ
    • マーケティング能力
    • 財務分析
    • 強みと弱み
    • 戦略の方向性
  • AstraZeneca
  • Bristol-Myers Squibb
  • Eli Lilly
  • GlaxoSmithKline
  • Johnson & Johnson
  • Merck
  • Novartis
  • Pfizer
  • Roche
  • Sanofi-Aventis
  • Wyeth

図表

目次
Product Code: VPPH912

This report provides industry executives with strategically significant competitor information and analysis of the leading players in the Global CNS Market.

The report provides a worldwide strategic overview of the pharmaceutical market, including:

  • Sales forecast for major product segments: ethical, OTC, generics.
  • Sales forecast for major drug categories.
  • Sales forecasts by geographical region: North America, Europe, Japan, Latin America.

In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies.

The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.

The report's major objectives include:

  • To establish a comprehensive, factual, annually updated and cost-effective information based on performance, capabilities, goals and strategies of the leading players in the global CNS drug market.
  • To help current suppliers realistically assess their financial, technological and marketing capabilities vis-a-vis the leading competitors.
  • To assist potential market entrants in evaluating prospective acquisition and joint venture candidates.
  • To complement organizations' internal competitor information gathering efforts with strategic analysis, data interpretation and insight.

Contains: 1,353 pages and 127 tables.

Table of Contents

Abbott

  • Executive Summary
  • Ownership
  • Business Evolution
  • Organization and Management
  • Major Facilities
  • Product Portfolio and Technological Know-How
  • Marketing Capabilities
  • Financial Analysis
  • Strengths and Weaknesses
  • Strategic Direction

AstraZeneca

  • Executive Summary
  • Ownership
  • Business Evolution
  • Organization and Management
  • Major Facilities
  • Product Portfolio and Technological Know-How
  • Marketing Capabilities
  • Financial Analysis
  • Strengths and Weaknesses
  • Strategic Direction

Bristol-Myers Squibb

  • Executive Summary
  • Ownership
  • Business Evolution
  • Organization and Management
  • Major Facilities
  • Product Portfolio and Technological Know-How
  • Marketing Capabilities
  • Financial Analysis
  • Strengths and Weaknesses
  • Strategic Direction

Eli Lilly

  • Executive Summary
  • Ownership
  • Business Evolution
  • Organization and Management
  • Major Facilities
  • Product Portfolio and Technological Know-How
  • Marketing Capabilities
  • Financial Analysis
  • Strengths and Weaknesses
  • Strategic Direction

GlaxoSmithKline

  • Executive Summary
  • Ownership
  • Business Evolution
  • Organization and Management
  • Major Facilities
  • Product Portfolio and Technological Know-How
  • Marketing Capabilities
  • Financial Analysis
  • Strengths and Weaknesses
  • Strategic Direction

Johnson & Johnson

  • Executive Summary
  • Ownership
  • Business Evolution
  • Organization and Management
  • Major Facilities
  • Product Portfolio and Technological Know-How
  • Marketing Capabilities
  • Financial Analysis
  • Strengths and Weaknesses
  • Strategic Direction

Merck

  • Executive Summary
  • Ownership
  • Business Evolution
  • Organization and Management
  • Major Facilities
  • Product Portfolio and Technological Know-How
  • Marketing Capabilities
  • Financial Analysis
  • Strengths and Weaknesses
  • Strategic Direction

Novartis

  • Executive Summary
  • Ownership
  • Business Evolution
  • Organization and Management
  • Major Facilities
  • Product Portfolio and Technological Know-How
  • Marketing Capabilities
  • Financial Analysis
  • Strengths and Weaknesses
  • Strategic Direction

Pfizer

  • Executive Summary
  • Ownership
  • Business Evolution
  • Organization and Management
  • Major Facilities
  • Product Portfolio and Technological Know-How
  • Marketing Capabilities
  • Financial Analysis
  • Strengths and Weaknesses
  • Strategic Direction

Roche

  • Executive Summary
  • Ownership
  • Business Evolution
  • Organization and Management
  • Major Facilities
  • Product Portfolio and Technological Know-How
  • Marketing Capabilities
  • Financial Analysis
  • Strengths and Weaknesses
  • Strategic Direction

Sanofi-Aventis

  • Executive Summary
  • Ownership
  • Business Evolution
  • Organization and Management
  • Major Facilities
  • Product Portfolio and Technological Know-How
  • Marketing Capabilities
  • Financial Analysis
  • Strengths and Weaknesses
  • Strategic Direction

Wyeth

  • Executive Summary
  • Ownership
  • Business Evolution
  • Organization and Management
  • Major Facilities
  • Product Portfolio and Technological Know-How
  • Marketing Capabilities
  • Financial Analysis
  • Strengths and Weaknesses
  • Strategic Direction

List of Tables

  • Abbott Sales and Operating Profit Growth
  • Abbott Sales by Therapeutic Category/Business
  • Abbott Sales Growth by Therapeutic Category/business
  • Abbott Sales by Major Drug/Business
  • Abbott Sales Growth by Major Drug/Business
  • Abbott Sales by Major Drug/Business and Geographic Region
  • Abbott Sales by Geographic Region and Country
  • Abbott Sales Growth by Geographic Region and Country
  • AstraZeneca Sales and Operating Profit Growth
  • AstraZeneca Sales by Therapeutic Category/Business
  • AstraZeneca Sales Growth by Therapeutic Category/business
  • AstraZeneca Sales by Major Drug/Business
  • AstraZeneca Sales Growth by Major Drug/Business
  • AstraZeneca Sales by Major Drug/Business and Geographic Region
  • AstraZeneca Sales by Geographic Region and Country
  • AstraZeneca Sales Growth by Geographic Region and Country
  • Bristol-Myers Squibb Sales and Operating Profit Growth
  • Bristol-Myers Squibb Sales By Major Drug and Geographic Region
  • Bristol-Myers Squibb Sales Growth by Major Drug
  • Bristol-Myers Squibb Sales By Geographic Region
  • Bristol-Myers Squibb Estimated Sales Growth By Geographic Region
  • Historical Financials
  • Bristol-Myers Squibb Sales and Operating Profit growth
  • Bristol-Myers Squibb Sales by Major Division
  • Bristol-Myers Squibb Sales by Major Division and Geographic Region
  • Bristol-Myers Squibb Sales Growth by Major Division
  • Bristol-Myers Squibb Sales by Therapeutic Category
  • Bristol-Myers Squibb Sales by Therapeutic Category and Geographic Region
  • Bristol-Myers Squibb Sales Growth by Therapeutic Category
  • Bristol-Myers Squibb Sales by Major Drug
  • Bristol-Myers Squibb Sales Growth by Major Drug
  • Bristol-Myers Squibb Sales by Product Line
  • Bristol-Myers Squibb Sales Growth by Product Line
  • Bristol-Myers Squibb Sales by Geographic Region
  • Bristol-Myers Squibb Sales Growth by Geographic Region
  • Bristol-Myers Squibb Other Health Care Sales by Product
  • Bristol-Myers Squibb Sales Growth by Geographic Region
  • Eli Lilly Sales and Operating Profit Growth
  • Eli Lilly Sales by Therapeutic Category
  • Eli Lilly Sales Growth by Therapeutic Category
  • Eli Lilly Sales by Major Product
  • Eli Lilly Sales Growth by Major Drug
  • Eli Lilly Sales by Geographic Region
  • Eli Lilly Sales Growth by Geographic Region
  • Eli Lilly Sales and Operating Profit Growth
  • GlaxoSmithKline Sales by Business Segment
  • GlaxoSmithKline Sales Growth by Business Segment
  • GlaxoSmithKline Operating Profit and Margins by Business Segment
  • GlaxoSmithKline Operating Profit by Business Segment
  • GlaxoSmithKline Sales and Operating Profit Growth
  • GlaxoSmithKline Sales by Major Drug
  • GlaxoSmithKline Sales by Drug and Geographic Region
  • GlaxoSmithKline Sales by Therapeutic Category
  • GlaxoSmithKline Sales Growth by Therapeutic Category
  • GlaxoSmithKline Sales by Geographic Region and Country
  • GlaxoSmithKline Sales Growth by Geographic Region
  • GlaxoSmithKline Consumer Healthcare Sales by Product Line
  • GlaxoSmithKline Consumer Healthcare Sales Growth By Product Line
  • Johnson & Johnson Sales by Geographic Region and Country
  • Johnson & Johnson Sales Growth by Geographic Region
  • Johnson & Johnson Sales by Business Segment and Geographic Region
  • Johnson & Johnson Sales and Operating Profit Growth
  • Johnson & Johnson Sales by Major Drug
  • Johnson & Johnson Pharmaceutical Sales Growth by Major Drug
  • Johnson & Johnson Consumer Segment Sales by Product Line
  • Johnson & Johnson Consumer Segment Sales Growth by Product Line
  • Merck Sales and Operating Profit Growth
  • Merck Sales by Geographic Region
  • Merck Sales Growth by Geographic Region
  • Merck Sales by Therapeutic Category
  • Merck Sales Growth by Therapeutic Category
  • Merck Sales by Major Drug
  • Merck Sales Growth by Major Drug
  • Merck Sales by Major Drug and Geographic Region
  • Novartis Sales and Operating Profit Growth
  • Novartis Sales by Business Segment
  • Novartis Sales Growth by Business Segment
  • Novartis Operating Profit by Business Segment
  • Novartis Operating Profit Growth by Business Segment
  • Novartis Sales by Country
  • Novartis Sales Growth by Country
  • Novartis Sales by Therapeutic Category
  • Novartis Sales Growth by Therapeutic Category
  • Novartis Sales of Top 20 Drugs
  • Novartis Sales Growth by Major Drug
  • Pfizer Sales by Division
  • Pfizer Sales and Operating Profit Growth
  • Pfizer Sales by Therapeutic Category
  • Pfizer Sales by Major Product
  • Pfizer Sales Growth by Major Product
  • Pfizer Sales by Geographic Region
  • Pfizer Sales Growth by Geographic Region
  • Roche Sales and Operating Profit Growth
  • Roche Sales by Major Division
  • Roche Sales Growth by Business Segment
  • Roche Sales by Geographic Region
  • Roche Sales Growth by Geographic Region
  • Roche Sales and Operating Profit Growth
  • Roche Sales by Division
  • Roche Operating Profit by Division
  • Roche Operating Profit Growth by Division
  • Roche Sales by Therapeutic Category
  • Roche Sales of Top 20 Products
  • Sanofi-Aventis Sales and Operating Profit Growth
  • Sanofi-Aventis Sales by Business Segment
  • Sanofi-Aventis Sales Growth by Business Segment
  • Sanofi-Aventis Sales of Top 15 Drugs
  • Sanofi-Aventis Sales Growth of Top 15 Drugs
  • Sanofi-Aventis Sales of 15 Major Drugs and Geographic Region
  • Sanofi-Aventis Sales by Geographic Region
  • Sanofi-Aventis Vaccine Sales by Major Product
  • Wyeth Sales by Business Segment
  • Wyeth Sales Growth by Business Segment
  • Wyeth Sales and Operating Profit Growth
  • Wyeth Sales by Therapeutic Category
  • Wyeth Sales by Major Drug
  • Wyeth Consumer Healthcare Sales by Product
  • Wyeth Consumer Healthcare Sales Growth by Product
Back to Top